Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Capsule, founded in 2015 and headquartered in New York, is revolutionizing the pharmacy industry with its innovative mobile commerce platform. The company offers same-day prescription delivery and allows customers to manage their medications through their smartphones, catering to the growing demand for convenient healthcare solutions.
Since its inception, Capsule has demonstrated impressive growth and attracted significant investor interest. The company has successfully raised $570 million across multiple funding rounds, with its latest Series D round in April 2021 securing $300 million at a valuation of $1 billion. This substantial funding and valuation highlight Capsule's strong market position and potential for future expansion.
While there is currently no official news regarding Capsule's IPO prospects, the company's rapid growth and substantial funding history suggest it may be well-positioned for a potential public offering in the future. However, it's important to note that any discussions about a possible IPO remain speculative at this time.
Several factors could influence Capsule's decision to go public, including market conditions, the company's financial performance, and its long-term growth strategy. The competitive landscape in the digital pharmacy sector, featuring players like Alto Pharmacy and Truepill, may also play a role in Capsule's strategic decisions moving forward.
Investors interested in the digital health and pharmacy sectors should keep an eye on Capsule's developments, as the company continues to innovate and expand its services in the rapidly evolving healthcare technology market.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Capsule's IPO prospects remain uncertain, investors interested in the digital pharmacy and healthcare technology sector don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry disruptors like Capsule, with lower minimum investments than traditional private equity options. By leveraging our expertise, we help you diversify your portfolio with pre-IPO investments in emerging healthcare technology leaders.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
